Payment overview · 2025
General Payments
$37.65
2 reported records · 2 companies
Healthcare provider profile · identity verified
Ryan M Siewert, MD
Allopathic & Osteopathic Physicians|Family Medicine · WILLISTON, ND · NPI 1528355500
Verified facts
What the public records show
CMS Open Payments records show Ryan M Siewert, MD received $37.65 in general payments during 2025 across 2 reported records.
Exact Sciences Corporation accounted for 58.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $22.01 | 58.5% | 1 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$15.64 | 41.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $37.65 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $22.01 | 1 | 2025 |
Source payment records
|
|||||
| MINIMED 780G Normalized: minimed 780g |
Device | Medtronic, Inc. | $15.64 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 511 | 116 |
| Atorvastatin Calcium | Atorvastatin Calcium | 508 | 143 |
| Lisinopril | Lisinopril | 357 | 81 |
| Amlodipine Besylate | Amlodipine Besylate | 351 | 81 |
| Losartan Potassium | Losartan Potassium | 321 | 84 |
| Furosemide | Furosemide | 309 | 69 |
| Omeprazole | Omeprazole | 290 | 61 |
| Hydrochlorothiazide | Hydrochlorothiazide | 261 | 71 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 250 | 69 |
| Gabapentin | Gabapentin | 236 | 45 |
| Metoprolol Succinate | Metoprolol Succinate | 231 | 65 |
| Potassium Chloride | Potassium Chloride | 211 | 55 |
| Pantoprazole Sodium | Pantoprazole Sodium | 208 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 201 | 45 |
| Simvastatin | Simvastatin | 191 | 46 |
| Sertraline Hcl | Sertraline Hcl | 188 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 176 | 36 |
| Metformin Hcl Er | Metformin Hcl | 171 | 44 |
| Metformin Hcl | Metformin Hcl | 149 | 38 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 148 | 29 |
| Tramadol Hcl | Tramadol Hcl | 141 | 27 |
| Tamsulosin Hcl | Tamsulosin Hcl | 138 | 34 |
| Eliquis | Apixaban | 127 | 27 |
| Lorazepam | Lorazepam | 127 | 25 |
| Trazodone Hcl | Trazodone Hcl | 123 | 21 |
| Allopurinol | Allopurinol | 116 | 21 |
| Celecoxib | Celecoxib | 115 | 26 |
| Ozempic | Semaglutide | 93 | 18 |
| Finasteride | Finasteride | 90 | 23 |
| Clonazepam | Clonazepam | 89 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 88 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 85 | 31 |
| Spironolactone | Spironolactone | 83 | 24 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 77 | 24 |
| Montelukast Sodium | Montelukast Sodium | 74 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 70 | 19 |
| Pioglitazone Hcl | Pioglitazone Hcl | 70 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 70 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 69 | 14 |
| Ventolin Hfa | Albuterol Sulfate | 67 | 21 |
| Baclofen | Baclofen | 66 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 65 | 28 |
| Prednisone | Prednisone | 65 | 22 |
| Tresiba Flextouch U-200 | Insulin Degludec | 65 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 64 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 62 | 13 |
| Trulicity | Dulaglutide | 61 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 60 | suppressed |
| Famotidine | Famotidine | 57 | 11 |
| Meloxicam | Meloxicam | 57 | 13 |
| Alprazolam | Alprazolam | 56 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 53 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 52 | 11 |
| Jardiance | Empagliflozin | 52 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 52 | 13 |
| Xarelto | Rivaroxaban | 52 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 51 | suppressed |
| Glipizide Er | Glipizide | 50 | suppressed |
| Glimepiride | Glimepiride | 49 | 16 |
| Farxiga | Dapagliflozin Propanediol | 46 | suppressed |
| Pregabalin | Pregabalin | 44 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 42 | 14 |
| Temazepam | Temazepam | 42 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 40 | suppressed |
| Levetiracetam | Levetiracetam | 40 | suppressed |
| Mirtazapine | Mirtazapine | 40 | suppressed |
| Mounjaro | Tirzepatide | 40 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 40 | suppressed |
| Chlorthalidone | Chlorthalidone | 39 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 39 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 38 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 38 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 38 | suppressed |
| Sucralfate | Sucralfate | 38 | suppressed |
| Novolog Flexpen | Insulin Aspart | 36 | suppressed |
| Synthroid | Levothyroxine Sodium | 35 | suppressed |
| Bupropion Xl | Bupropion Hcl | 34 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 31 | suppressed |
| Atenolol | Atenolol | 31 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 31 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 31 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 29 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 29 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 14 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 27 | suppressed |
| Ezetimibe | Ezetimibe | 26 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 26 | suppressed |
| Diazepam | Diazepam | 25 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 25 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Gemfibrozil | Gemfibrozil | 24 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 24 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | 12 |
| Budesonide | Budesonide | 23 | suppressed |
| Lovastatin | Lovastatin | 23 | suppressed |
| Digoxin | Digoxin | 22 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 21 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Carvedilol | Carvedilol | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Tradjenta | Linagliptin | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Azithromycin | Azithromycin | 19 | 19 |
| Colestipol Hcl | Colestipol Hcl | 19 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Memantine Hcl | Memantine Hcl | 19 | suppressed |
| Novolog | Insulin Aspart | 19 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 19 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Aripiprazole | Aripiprazole | 17 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Levemir Flexpen | Insulin Detemir | 17 | suppressed |
| Methylprednisolone | Methylprednisolone | 17 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 15 |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Humalog | Insulin Lispro | 15 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Eplerenone | Eplerenone | 14 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Latanoprost | Latanoprost | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Nizatidine | Nizatidine | 12 | suppressed |
| Olanzapine | Olanzapine | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Cephalexin | Cephalexin | 11 | 11 |
| Fentanyl | Fentanyl | 11 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 11 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Januvia | Sitagliptin Phosphate | 11 | suppressed |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | Insulin Pump Cart,auto,bt,g6/7 | 11 | suppressed |
| Ritalin | Methylphenidate Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $37.65 · 2 records | Exact Sciences Corporation | MINIMED 780G, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error